Rockin Robin SongFlying The Web For News.
RobinPost Logo Amazon Prime Deals





Globe NewsWire News Distribution Service


Rumble Has Successfully Secured the Support of 85% of Northern Data’s Share Capital In Total, 46% of Northern Data Shares not subject to Transaction Support Agreements Have Been Tendered Additional Acceptance Period Expired on June 1, 2026 – Exchange Offer No Longer Open for Acceptance


Posted: 2026-06-08 04:01:00

Get Full News Story On GlobeNewsWire Press Release Service




More News From This Category
Press Release: Share buyback programme – week 23
Mon, 08 Jun 2026 07:07:37 +0000

Nasdaq CopenhagenEuronext DublinLondon Stock ExchangeDanish Financial Supervisory AuthorityOther stakeholders Date        8 June 2026 Share buyback programme – week 23 The share buyback programme runs in the period 6 May 2026 up to and including 7 August 2026, see company announcement of 6 May 2026.

Read More ...


Press Release: STLA IMPORTANT DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Stellantis N.V. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class Action – STLA
Mon, 08 Jun 2026 01:07:37 +0000

NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock on the New York Stock Exchange (“NYSE”) of Stellantis N.V. (NYSE: STLA) between February 26, 2025 and February 5, 2026, inclusive (the “Class Period”), of the important June 8, 2026 lead plaintiff…

Read More ...


Press Release: He Predicted Gold at $5,000. Now He Says This $2 Stock Could Be Even Bigger.
Sun, 07 Jun 2026 22:07:38 +0000

Washington, D.C., June 07, 2026 (GLOBE NEWSWIRE) -- When Jim Rickards told the world gold would hit $5,000 an ounce, most people laughed. Now gold has crossed that milestone and is heading higher. Nobody is laughing anymore.

Read More ...


Press Release: Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis
Sun, 07 Jun 2026 19:07:37 +0000

Company announcement No. 21 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity

Read More ...


Related Bing News Results
The 10 best press release distribution services for 2026
Sat, 06 Jun 2026 04:52:00 GMT
From AI-indexed wire distribution to boutique editorial review, these are the press release services that deliver real publisher placements without legacy wire pricing.


















Blow Us A Whistle


Related Product Search/Búsqueda de productos relacionados

Amazon Logo

Visit Our New Print-On-Demand Stores On Printify and Zazzle
Printify Zazzle